UBS analyst Peter Grom maintains a "Neutral" rating for Scotts Miracle Gro (SMG) but lowers the price target from $71 to $68, a 4.23% decrease. This reflects a cautious stance on the stock amid current market conditions. The average one-year price target from six analysts is $76.33, with an upside of 24.63% from the current price of $61.25. The average brokerage recommendation is 2.2, indicating "Outperform" status. The estimated GF Value in one year is $59.83, suggesting a downside of 2.32% from the current price.
UBS analyst Peter Grom has maintained a "Neutral" rating for Scotts Miracle-Gro (SMG), while lowering the price target from $71.00 to $68.00. This adjustment represents a 4.23% decrease from the previous target, reflecting a cautious stance on the stock amid current market conditions [1].
The latest move by UBS comes on the heels of several recent analyst ratings and price target adjustments for SMG. In July 2025, Truist Securities maintained a "Buy" rating and raised the price target from $75.00 to $80.00, a 6.67% increase [2]. Wells Fargo also maintained an "Overweight" rating and raised the price target from $72.00 to $75.00, a 4.17% increase [2].
Based on the one-year price targets offered by six analysts, the average target price for SMG is $76.33, with a high estimate of $82.00 and a low estimate of $71.00. This average target implies an upside of 24.63% from the current price of $61.25 [1]. The average brokerage recommendation from 10 firms is 2.2, indicating an "Outperform" status [1].
GuruFocus estimates the GF Value for SMG in one year to be $59.83, suggesting a downside of 2.32% from the current price of $61.25 [1]. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at, calculated based on historical multiples and future performance estimates.
References:
[1] https://www.gurufocus.com/news/3022956/ubs-maintains-neutral-rating-on-smg-but-lowers-price-target-to-68-smg-stock-news
[2] https://www.marketscreener.com/news/scotts-miracle-gro-earnings-call-transcript-smg-usq-transcript-2025-07-30-ce7c5fddd189f62d
Comments
No comments yet